2022
DOI: 10.1016/j.tox.2022.153119
|View full text |Cite
|
Sign up to set email alerts
|

SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(13 citation statements)
references
References 34 publications
1
9
0
Order By: Relevance
“…[42,43] In a cohort of more than 2000 patients treated with doxorubicin chemotherapy, a follow-up study found that 9% of patients showed cardiotoxicity with a decrease in LVEF of 10% −50%. [44,45] Our results found that DOX exposure caused the decrease of EF and SV in rats, which is in accordance with previous reports in mice, [46] whereas VitB 6 supplement could increase EF and SV. BNP is another indicator to evaluate cardiac function, which will be released into the blood in large quantities [47,48] when the heart was injured by DOX.…”
Section: F I G U R E 4 (See Caption On Next Page)supporting
confidence: 92%
“…[42,43] In a cohort of more than 2000 patients treated with doxorubicin chemotherapy, a follow-up study found that 9% of patients showed cardiotoxicity with a decrease in LVEF of 10% −50%. [44,45] Our results found that DOX exposure caused the decrease of EF and SV in rats, which is in accordance with previous reports in mice, [46] whereas VitB 6 supplement could increase EF and SV. BNP is another indicator to evaluate cardiac function, which will be released into the blood in large quantities [47,48] when the heart was injured by DOX.…”
Section: F I G U R E 4 (See Caption On Next Page)supporting
confidence: 92%
“… 307 Overexpression of SIRT4 inhibits ROS production and autophagy by activating the Akt/mTOR signaling pathway. 308 Furthermore, the SIRT4/optic atrophy 1 axis is causally linked to mitochondrial dysfunction and altered mitochondrial dynamics that translates into aging-associated decreased mitophagy. 301 So far, there are few relevant studies on SIRT4 regulation of autophagy.…”
Section: Introductionmentioning
confidence: 99%
“…Wang et al found thatSIRT4 overexpression in hepatocellular carcinomas could activate autophagy by inhibiting glutamine metabolism and increasing ADP/AMP levels, thereby activating the LKB1/AMPKα/mTOR signaling pathway [ 16 ]. In the cardiovascular system, SIRT4 overexpression has been reported to protect cardiomyocytes from doxorubicin-induced cardiotoxicity by inhibiting Akt/mTOR-dependent autophagy [ 53 ]. In the pancreas, SIRT4 can deactivate autophagic function by deregulating AMPK and directly inhibiting insulin secretion [ 54 ].…”
Section: Discussionmentioning
confidence: 99%